148 related articles for article (PubMed ID: 35538298)
21. Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort.
Cooperberg MR; Davicioni E; Crisan A; Jenkins RB; Ghadessi M; Karnes RJ
Eur Urol; 2015 Feb; 67(2):326-33. PubMed ID: 24998118
[TBL] [Abstract][Full Text] [Related]
22. An evidence review of active surveillance in men with localized prostate cancer.
Ip S; Dahabreh IJ; Chung M; Yu WW; Balk EM; Iovin RC; Mathew P; Luongo T; Dvorak T; Lau J
Evid Rep Technol Assess (Full Rep); 2011 Dec; (204):1-341. PubMed ID: 23126653
[TBL] [Abstract][Full Text] [Related]
23. Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database.
Keto CJ; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
BJU Int; 2012 Aug; 110(4):492-8. PubMed ID: 22094083
[TBL] [Abstract][Full Text] [Related]
24. The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation.
Ouellet V; Aprikian A; Bergeron A; Brimo F; Bristow RG; Chevalier S; Drachenberg D; Fazli L; Fleshner NE; Gleave M; Karakiewicz P; Klotz L; Lacombe L; Lattouf JB; van der Kwast T; Squire JA; Latour M; Trudel D; Mes-Masson AM; Saad F
BMC Urol; 2018 Sep; 18(1):78. PubMed ID: 30200929
[TBL] [Abstract][Full Text] [Related]
25. Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing.
Bjurlin MA; Carter HB; Schellhammer P; Cookson MS; Gomella LG; Troyer D; Wheeler TM; Schlossberg S; Penson DF; Taneja SS
J Urol; 2013 Jun; 189(6):2039-46. PubMed ID: 23485507
[TBL] [Abstract][Full Text] [Related]
26. Variability in date of prostate cancer diagnosis: a comparison of cancer registry, pathology report, and electronic health data sources.
Porter KR; Chao C; Quinn VP; Hsu JW; Jacobsen SJ
Ann Epidemiol; 2014 Nov; 24(11):855-60. PubMed ID: 25282324
[TBL] [Abstract][Full Text] [Related]
27. Psychosocial interventions for men with prostate cancer.
Parahoo K; McDonough S; McCaughan E; Noyes J; Semple C; Halstead EJ; Neuberger MM; Dahm P
Cochrane Database Syst Rev; 2013 Dec; (12):CD008529. PubMed ID: 24368598
[TBL] [Abstract][Full Text] [Related]
28. Tool-supported Interactive Correction and Semantic Annotation of Narrative Clinical Reports.
Zvára K; Tomečková M; Peleška J; Svátek V; Zvárová J
Methods Inf Med; 2017 May; 56(3):217-229. PubMed ID: 28451691
[TBL] [Abstract][Full Text] [Related]
29. Critical Care Health Informatics Collaborative (CCHIC): Data, tools and methods for reproducible research: A multi-centre UK intensive care database.
Harris S; Shi S; Brealey D; MacCallum NS; Denaxas S; Perez-Suarez D; Ercole A; Watkinson P; Jones A; Ashworth S; Beale R; Young D; Brett S; Singer M
Int J Med Inform; 2018 Apr; 112():82-89. PubMed ID: 29500026
[TBL] [Abstract][Full Text] [Related]
30. Use of record linkage to evaluate treatment outcomes and trial eligibility in a real-world metastatic prostate cancer population in Scotland.
Baillie K; Mueller T; Pan J; Laskey J; Bennie M; Crearie C; Kavanagh K; Alvarez-Madrazo S; Morrison D; Clarke J; Keel A; Cameron D; Wu O; Kurdi A; Jones RJ
Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):653-663. PubMed ID: 32316077
[TBL] [Abstract][Full Text] [Related]
31. Evaluating the Four Kallikrein Panel of the 4Kscore for Prediction of High-grade Prostate Cancer in Men in the Canary Prostate Active Surveillance Study.
Lin DW; Newcomb LF; Brown MD; Sjoberg DD; Dong Y; Brooks JD; Carroll PR; Cooperberg M; Dash A; Ellis WJ; Fabrizio M; Gleave ME; Morgan TM; Nelson PS; Thompson IM; Wagner AA; Zheng Y;
Eur Urol; 2017 Sep; 72(3):448-454. PubMed ID: 27889277
[TBL] [Abstract][Full Text] [Related]
32. The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation.
Mowatt G; Scotland G; Boachie C; Cruickshank M; Ford JA; Fraser C; Kurban L; Lam TB; Padhani AR; Royle J; Scheenen TW; Tassie E
Health Technol Assess; 2013 May; 17(20):vii-xix, 1-281. PubMed ID: 23697373
[TBL] [Abstract][Full Text] [Related]
33. Validating electronic cancer quality measures at Veterans Health Administration.
Shelton JB; Skolarus TA; Ordin D; Malin J; Antonio A; Ryoo J; Saigal CS
Am J Manag Care; 2014; 20(12):1041-7. PubMed ID: 25526392
[TBL] [Abstract][Full Text] [Related]
34. Impact of Radical Prostatectomy on Long-Term Oncologic Outcomes in a Matched Cohort of Men with Pathological Node Positive Prostate Cancer Managed by Castration.
Bhindi B; Rangel LJ; Mason RJ; Gettman MT; Frank I; Kwon ED; Tollefson MK; Thompson RH; Boorjian SA; Karnes RJ
J Urol; 2017 Jul; 198(1):86-91. PubMed ID: 28130104
[TBL] [Abstract][Full Text] [Related]
35. Methodological description of clinical research data collection through electronic medical records in a center participating in an international multicenter study.
Queiroz VNF; Oliveira ADCM; Chaves RCF; Moura LAB; César DS; Takaoka F; Serpa Neto A
Einstein (Sao Paulo); 2019; 17(4):eAE4791. PubMed ID: 31553359
[TBL] [Abstract][Full Text] [Related]
36. Laparoscopic and robotic-assisted versus open radical prostatectomy for the treatment of localised prostate cancer.
Ilic D; Evans SM; Allan CA; Jung JH; Murphy D; Frydenberg M
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD009625. PubMed ID: 28895658
[TBL] [Abstract][Full Text] [Related]
37. Staging for prostate cancer: time to incorporate pretreatment prostate-specific antigen and Gleason score?
Roach M; Weinberg V; Sandler H; Thompson I
Cancer; 2007 Jan; 109(2):213-20. PubMed ID: 17167758
[TBL] [Abstract][Full Text] [Related]
38. Tissue polypeptide-specific antigen (TPS) immunoassay in the diagnosis and clinical staging of prostatic carcinoma. Comparison with prostate-specific antigen (PSA).
Ceriani L; Giovanella L; Salvadore M; Bono AV; Roncari G
Int J Biol Markers; 1997; 12(1):27-34. PubMed ID: 9176715
[TBL] [Abstract][Full Text] [Related]
39. A method for cohort selection of cardiovascular disease records from an electronic health record system.
Abrahão MTF; Nobre MRC; Gutierrez MA
Int J Med Inform; 2017 Jun; 102():138-149. PubMed ID: 28495342
[TBL] [Abstract][Full Text] [Related]
40. ePCR: an R-package for survival and time-to-event prediction in advanced prostate cancer, applied to real-world patient cohorts.
Laajala TD; Murtojärvi M; Virkki A; Aittokallio T
Bioinformatics; 2018 Nov; 34(22):3957-3959. PubMed ID: 29912284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
